Sales of Fulcare were drastically increased with KRW 25.2 billion… the ‘synergy’ effect of pharmaceutical distribution partnerships was the reason

As sales of the athlete’s foot and hand treatment ‘Fulcare’ have been tripled, the case have been called as an example a ‘Win-Win’ case between a pharmaceutical company and distribution companies.

Although Fulcare recorded sales worth of KRW 8.8 billion in 2013, the sales were increased by 2.9 times with KRW 25.2 billion in November 2014 and are expected to hit a triple increase by this Decemb...